March 2017 Central Nervous System

Medication Can Reduce Risky Behavior in Kids and Teens with ADHD

March 20, 2017

ADHD Watch

Although children and teenagers who are diagnosed with attention-deficit/hyperactivity disorder are more likely to engage in risky behaviors such as dangerous driving and drug use, a recent study has suggested that the use of ADHD medications could help prevent these behaviors.

Antipsychotic Drugs Could Increase Mortality in Parkinson's Disease Patients

March 20, 2017

CNS Watch

Antipsychotic medications may do more harm than good in patients with Parkinson’s disease, with a recent study indicating that the use of these drugs can lead to a heightened mortality risk in this population.

Early Treatment of MS Signs May Slow Disease Progression

March 20, 2017

CNS Watch

A recent study has suggested that starting patients on multiple sclerosis medication soon after they show initial signs of the disease could prolong the time before the condition becomes fully diagnosable.

Leadership in Action

March 20, 2017

RESPy Awards

Throughout her studies at the University of Oklahoma College of Pharmacy (OUCOP), Wei Kwan Yuet has demonstrated her talents as a leader and future health care provider.

Challenge Mounted to Inadequate Medicaid Payment Rates

March 20, 2017

Legal Focus

Can providers in a state’s Medicaid program sue program administrators for establishing low payment rates, for beneficiary services, claiming that these rates violate mandates in the federal Medicaid statute?

Substance Abuse in Rural America

March 20, 2017

Legal Focus

Much of rural America has been inundated with prescription drug abuse for decades. Although this issue continues to plague society, many overdose deaths are now occurring because of polydrug abuse, of which heroin is a major contributor.

Stelara

March 20, 2017

Rx Product News Profile

The FDA has approved Stelara injection for the treatment of adults with moderately to severely active Crohn’s disease who have failed, or were intolerant to, treatment with immunomodulators or corticosteroids.